僅用于工業(yè)應(yīng)用或科學(xué)研究,不可用于人類(lèi)或動(dòng)物的臨床診斷或治療,非藥用. Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody directed at an N‐terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research